
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/08/2025 | Q1 | -- | $4.4B | $0.34 | -- | -- |
02/25/2025 | Q4 | -- | $6.1B | $0.37 | -- | -- |
11/07/2024 | Q3 | -- | $4.5B | $0.17 | -- | -- |
07/30/2024 | Q2 | -- | $4.7B | $0.07 | -- | -- |
05/07/2024 | Q1 | -- | $4B | $0.42 | -- | -- |
12/31/2023 | Q4 | -- | $5.4B | $0.36 | -- | -- |
09/30/2023 | Q3 | -- | $3.7B | $0.09 | -- | -- |
06/30/2023 | Q2 | -- | $4.2B | $0.15 | -- | -- |
03/31/2023 | Q1 | -- | $3.3B | $0.03 | -- | -- |
12/31/2022 | Q4 | -- | $4.9B | $0.24 | -- | -- |
11/03/2022 | Q3 | -- | $3.4B | $0.35 | -- | -- |
06/30/2022 | Q2 | -- | $3.8B | $0.18 | -- | -- |
03/31/2022 | Q1 | -- | $3.4B | $0.07 | -- | -- |
12/31/2021 | Q4 | -- | $5.2B | $0.36 | -- | -- |
09/30/2021 | Q3 | -- | $3.8B | $0.05 | -- | -- |
06/30/2021 | Q2 | -- | $4.3B | $0.19 | -- | -- |
03/31/2021 | Q1 | -- | $3.4B | -$0.00 | -- | -- |
12/31/2020 | Q4 | -- | $5.2B | $0.11 | -- | -- |
09/30/2020 | Q3 | -- | $3.7B | $0.08 | -- | -- |
06/30/2020 | Q2 | -- | $3.6B | $0.11 | -- | -- |
03/31/2020 | Q1 | -- | $2.9B | -$0.06 | -- | -- |
12/31/2019 | Q4 | -- | $5.1B | $0.34 | -- | -- |
09/30/2019 | Q3 | -- | $3.5B | $0.11 | -- | -- |
06/30/2019 | Q2 | -- | $3.6B | $0.27 | -- | -- |
03/31/2019 | Q1 | -- | $3.1B | $0.08 | -- | -- |
12/31/2018 | Q4 | -- | $4.6B | $0.25 | -- | -- |
09/30/2018 | Q3 | -- | $3.1B | $0.16 | -- | -- |
06/30/2018 | Q2 | -- | $3.7B | $0.06 | -- | -- |
03/31/2018 | Q1 | -- | $3B | $0.05 | -- | -- |
12/31/2017 | Q4 | -- | $4.3B | $0.01 | -- | -- |
09/30/2017 | Q3 | -- | $3B | $0.05 | -- | -- |
06/30/2017 | Q2 | -- | $3.4B | $0.16 | -- | -- |
03/31/2017 | Q1 | -- | $2.5B | $0.05 | -- | -- |
12/31/2016 | Q4 | -- | $4.3B | $0.14 | -- | -- |
09/30/2016 | Q3 | -- | $2.9B | $0.14 | -- | -- |
06/30/2016 | Q2 | -- | $3.3B | $0.14 | -- | -- |
03/31/2016 | Q1 | -- | $2.8B | $0.06 | -- | -- |
12/31/2015 | Q4 | -- | $4.4B | $0.35 | -- | -- |
09/30/2015 | Q3 | -- | $3.4B | $0.03 | -- | -- |
Leonardo SpA reported $4.4B worth of top line sales in its most recent quarter.
Leonardo SpA announced earnings per share of $0.34 which represents a beat of analyst forecast a -- per share.
Leonardo SpA reported $386.2M that represents $0.34 per share over the last quarter.
Leonardo SpA's earnings are forecast to grow from $1.01 per share to -- per share next year representing an increase of --.
Leonardo SpA's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.